Plunkett Research Online: BELLUS Health, Inc.

BELLUS HEALTH, INC. (BLU) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business.....


BELLUS HEALTH, INC.

Ticker: BLU
Exchange: TSE
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 514 680-4500
Fax: 514 680-4501
Address: 275 Armand-Frappier Boulevard
Laval, QC H7V 4A7 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Roberto BelliniCEO/Director/President
Ramzi BenamarCFO
See More
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture